Institutional investors hold a majority ownership of DVAX through the 86.68% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2016, these large investors purchased a net $2.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORDEA INVESTMENT MANAGEMENT AB ... Bought 35.9 Thousand shares of Dynavax Technologies Corp
FOX RUN MANAGEMENT LLC Bought 20.2 Thousand shares of Dynavax Technologies Corp